G57321FI

Summary
GlyTouCan ID
G57321FI
IUPAC Condensed
GalNAc(a1-
Motifs
Tn antigen
GlyConnect structure
GlyGen
ChEBI
PubChem Compound
PubChem Substance
The Human Metabolome Database
3D Structures
GlycoNAVI
G57321FI
GlycoShape
G57321FI
GLYCAM
DGalpNAca1-OH
Organisms
Taxonomic Hierarchy
GlycoGene Database (GGDB)
Displaying all 4 entries
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
C1GALT1 (not applicable)
G57321FI
Ser/Thr
G00031MO
Ser/Thr
ST6GALNAC1 CMP-Neu5Ac
G57321FI
O-glycan Synthesis
G36123IU
O-glycan Synthesis
ST6GALNAC1 CMP-Neu5Ac
G57321FI
Ser/Thr
G36123IU
Ser/Thr
B3GNT6 UDP-GlcNAc
G57321FI
[alpha]-pNP
G00035MO
[alpha]-pNP
Displaying entries 1 - 5 of 9 in total
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
C1GALT1 (not applicable)
G57321FI
Ser/Thr
G00031MO
Ser/Thr
ST6GALNAC1 CMP-Neu5Ac
G57321FI
[Ala-Thr(*)-Ala]2-7
G36123IU
[Ala-Thr(*)-Ala]2-7
ST6GALNAC1 CMP-Neu5Ac
G57321FI
O-glycan Synthesis
G36123IU
O-glycan Synthesis
ST6GALNAC1 CMP-Neu5Ac
G57321FI
Ser/Thr
G36123IU
Ser/Thr
ST6GALNAC4 CMP-Neu5Ac
G57321FI
benzyl
G36123IU
benzyl
Displaying entries 1 - 5 of 35 in total
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Reference
ST8SIA6 CMP-Neu5Ac
G57321FI
ST6GALNAC2 CMP-Neu5Ac
G57321FI
para-nitrophenol
ST6GAL2 CMP-Neu5Ac
G57321FI
para-nitrophenol
ST6GAL1 CMP-Neu5Ac
G57321FI
para-nitrophenol
ST6GALNAC3 CMP-Neu5Ac
G57321FI
Ser/Thr
GlycoEpitope
Epitope ID
EP0021
Epitope Name
Tn Antigen
Pathway
Displaying entries 1 - 10 of 57 in total
Pathway Name Organism
E.coli O101 Escherichia coli
E.coli O103 Escherichia coli
E.coli O107 Escherichia coli
E.coli O112ab Escherichia coli
E.coli O112ac Escherichia coli
E.coli O116 Escherichia coli
E.coli O117 Escherichia coli
E.coli O125ab Escherichia coli
E.coli O127 Escherichia coli
E.coli O128ab-H27 Escherichia coli
Sequence Descriptors
GlycoCT
RES
1b:a-dgal-HEX-1:5
2s:n-acetyl
LIN
1:1d(2+1)2n
WURCS
WURCS=2.0/1,1,0/[a2112h-1a_1-5_2*NCC/3=O]/1/
Literature
Displaying entries 31 - 40 of 2052 in total
PubMed ID Title First Author Publication Date Source
38348876 A combinatorial approach for achieving CNS-selective RNAi Ferguson CM 2024 Feb 13
  • PubChem
38227794 Safety and Tolerability of GalNAc3-Conjugated Antisense Drugs Compared to the Same-Sequence 2′-O-Methoxyethyl-Modified Antisense Drugs: Results from an Integrated Assessment of Phase 1 Clinical Trial Data Baker BF 2024 Feb 01
  • PubChem
39177802 Givosiran for the Treatment of Pediatric Acute Intermittent Porphyria Bujold KE 2024 Aug 22
  • PubChem
39126245 O-GlcNAcylation determines the function of the key O-GalNAc glycosyltransferase C1GalT1 in bladder cancer Jiang Y 2024 Aug 01
  • PubChem
38667801 Chemical Synthesis of Fucosylated Chondroitin Sulfate Tetrasaccharide with Fucosyl Branch at the 6-OH of GalNAc Residue Lv C 2024 Apr 19
  • PubChem
38479165 Research progress on asialoglycoprotein receptor-targeted radiotracers designed for hepatic nuclear medicine imaging Hua Y 2024 Apr 05
  • PubChem
38570436 Cross-Reactive Polyclonal Antibodies Raised Against GalNAc-Conjugated siRNA Recognize Mostly the GalNAc Moiety Ballman KK 2024 Apr 03
  • PubChem
38401583 Deficiency of polypeptide N-acetylgalactosamine transferase 9 contributes to a risk for Parkinson's disease via mitochondrial dysfunctions Peng Y 2024 Apr
  • PubChem
38708485 Recovery of chronic motor neuropathy due to acute intermittent porphyria after givosiran treatment in a young boy: a case report Mazzoli M 2024 Apr
  • PubChem
38995536 Integrating HexNAcQuest with Glycoproteomics Data Analysis Software to Distinguish HexNAc Isomers on Peptides Hou C 2024
  • PubChem
PubAnnotation
Displaying entries 6 - 10 of 10 in total
Title Authors Source Publication Date PubMed ID
Identification of distinct glycoforms of IgA1 in plasma from patients with immunoglobulin A (IgA) nephropathy and healthy individuals.
  • Lehoux S
  • Mi R
  • Aryal RP
  • Wang Y
  • Schjoldager KT
  • Clausen H
  • van Die I
  • Han Y
  • Chapman AB
  • Cummings RD
  • Ju T
Mol Cell Proteomics 2014 Nov 25071157
Human T cell activation results in extracellular signal-regulated kinase (ERK)-calcineurin-dependent exposure of Tn antigen on the cell surface and binding of the macrophage galactose-type lectin (MGL).
  • van Vliet SJ
  • Vuist IM
  • Lenos K
  • Tefsen B
  • Kalay H
  • García-Vallejo JJ
  • van Kooyk Y
J Biol Chem 2013 Sep 20 23918927
Immunological response from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PS A1 conjugates.
  • De Silva RA
  • Wang Q
  • Chidley T
  • Appulage DK
  • Andreana PR
J Am Chem Soc 2009 Jul 22 19552408
Two different glycosyltransferase defects that result in GalNAc alpha-O-peptide (Tn) expression.
  • King MJ
  • Chan A
  • Roe R
  • Warren BF
  • Dell A
  • Morris HR
  • Bartolo DC
  • Durdey P
  • Corfield AP
Glycobiology 1994 Jun 7949653
Carbohydrate receptor-mediated gene transfer to human T leukaemic cells.
  • Thurnher M
  • Wagner E
  • Clausen H
  • Mechtler K
  • Rusconi S
  • Dinter A
  • Birnstiel ML
  • Berger EG
  • Cotten M
Glycobiology 1994 Aug 7827404

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.2.1

Last updated: April 7, 2025